Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$127.59 - $203.08 $8.96 Million - $14.3 Million
-70,207 Reduced 66.1%
36,000 $7.29 Million
Q4 2022

Feb 07, 2023

BUY
$117.37 - $139.17 $2.52 Million - $2.99 Million
21,477 Added 25.35%
106,207 $13.6 Million
Q3 2022

Nov 09, 2022

BUY
$135.27 - $180.11 $4.59 Million - $6.11 Million
33,935 Added 66.81%
84,730 $11.6 Million
Q2 2022

Aug 05, 2022

BUY
$108.81 - $179.33 $5.53 Million - $9.11 Million
50,795 New
50,795 $8.99 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.